The time-series behavior of neutrophil-to-lymphocyte ratio is useful as a predictive marker in non-small cell lung cancer

BACKGROUND: Nivolumab improves the survival of advanced non-small cell lung cancer (NSCLC), but a significant number of patients still fail to benefit from this treatment. In this study, we evaluated the efficacy of the time-series behavior of neutrophil-to-lymphocyte ratio (NLR) in a complete blood...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiriu, Tatsunori, Yamamoto, Masatsugu, Nagano, Tatsuya, Hazama, Daisuke, Sekiya, Reina, Katsurada, Masahiro, Tamura, Daisuke, Tachihara, Motoko, Kobayashi, Kazuyuki, Nishimura, Yoshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814002/
https://www.ncbi.nlm.nih.gov/pubmed/29447258
http://dx.doi.org/10.1371/journal.pone.0193018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814002/
https://www.ncbi.nlm.nih.gov/pubmed/29447258
http://dx.doi.org/10.1371/journal.pone.0193018

Ejemplares similares